Page last updated: 2024-09-05

lenalidomide and Cardiomyopathy, Restrictive

lenalidomide has been researched along with Cardiomyopathy, Restrictive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finsterer, J; Höftberger, R; Regele, H; Stöllberger, C; Wöhrer, A	1

Other Studies

1 other study(ies) available for lenalidomide and Cardiomyopathy, Restrictive

Article	Year
Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2 Topics: Aged; Amyloidosis; Biopsy; Cardiomyopathy, Restrictive; Fatal Outcome; Female; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Muscular Diseases; Myocardium; Thalidomide	2013

Article

Year

Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2

Topics: Aged; Amyloidosis; Biopsy; Cardiomyopathy, Restrictive; Fatal Outcome; Female; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Muscular Diseases; Myocardium; Thalidomide

2013